Diagnostic Accuracy of Visual Inspection with Acetic Acid (VIA) and Conventional Pap Smear in Detecting Cervical Intraepithelial Neoplasia (CIN) in Women of Reproductive Age at a Tertiary Care Hospital
Keywords:
Cervical Cancer, Diagnostic Accuracy, Visual Inspection with Acetic Acid, Pap Smear, HistopathologyAbstract
Background: Cervical cancer, the second leading cause of cancer-related morbidity and mortality among women globally, requires timely diagnosis at its precancerous stage to reduce disease severity and mortality rates. Histopathology, though the gold standard for diagnosis, is invasive and costly. This study aimed to assess the diagnostic accuracy of two less invasive procedures, i.e., Visual Inspection with Acetic Acid (VIA) and Pap smear against histopathology, to identify the most accurate early cervical cancer detection method.
Objective: To compare the diagnostic accuracy of Visual Inspection with Acetic Acid (VIA) and Pap smear for detecting cervical lesions, using histopathology as a gold standard.
Study Design: A cross-sectional study
Duration and Setting: Arif Memorial Teaching Hospital, Lahore, from January 2024 to September 2024.
Methods: This study was conducted with 290 women of reproductive age. Following cervical visualization and inspection, Pap smears and VIA tests were performed. Positive findings on VIA and Pap smear prompted a biopsy. Sensitivity, specificity, positive and negative predictive values, and the overall accuracy of VIA and Pap smear were calculated relative to histopathology results.
Results: The study included women with a mean age of 35.18 ± 8.29 years. VIA showed sensitivity, specificity, PPV, NPV, and accuracy of 91.86%, 95.59%, 89.77%, 96.53%, and 94.48%, respectively, while the Pap smear exhibited values of 83.72%, 94.61%, 86.75%, 93.24%, and 91.38%, respectively.
Conclusion: VIA demonstrated higher diagnostic accuracy than the Pap smear in detecting cervical malignancy, suggesting it as a cost-effective, non-invasive option for early screening in resource-limited settings.
Keywords: Cervical Cancer, Diagnostic Accuracy, Visual Inspection with Acetic Acid, Pap Smear, Histopathology
References
1. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2019;8(2):e191-e203.
2. Gurung TK, Adhikari SP, Adhikari A, Shrestha R, Pun CM. Conventional pap smear cytology in a tertiary care center. J Coll Med Sci Nepal. 2021;17(2):117-123.
3. Chanthavilay P, Mayxay M, Phongsavan K, Marsden DE, White LJ, Moore L, et al. Accuracy of combined visual inspection with acetic acid and cervical cytology testing as a primary screening tool for cervical cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2015;16(14):5889-5897.
4. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Women Health. 2015;7:405-414.
5. Human papillomavirus and related diseases report [online]. Pakistan ICO/IARC Information Centre on HPV and Cancer. June 17, 2019. Available from: https://hpvcentre.net/statistics/reports/PAK.pdf. Accessed July 6, 2021.
6. Mahmud G, Tasnim N, Iqbal S. Comparison of visual inspection with acetic acid and Pap smear in cervical cancer screening at a tertiary care hospital. J Pak Med Assoc. 2013;63(8):1013-1016.
7. Rajakeerthana R, Swarnapriya K, Kavitha G. Comparison of Pap smear and colposcopy in the evaluation of unhealthy cervix among women visiting a tertiary care center: a hospital-based descriptive observational study. Nepal J Obstet Gynaecol. 2023;18(1):13-19.
8. Ali F, Munim TF, Nadeem S, Khatoon A, Shaukat N. Visual inspection of cervix with acetic acid (VIA): an effective method of screening for cervical cancer. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll. 2021;26(2):91-98.
9. Naz U, Hanif S. Agreement between visual inspection with acetic acid and Papanicolaou's smear as screening methods for cervical cancer. J Coll Physicians Surg Pak. 2014;24(4):228-231.
10. Patel SD, Airao BB. A study of Pap smear examination at a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2022;11(11):3063-3067.
11. Nur AN, Chowdhury SR, Ahmed N. Colposcopic detection of CIN in patients with clinically abnormal cervix at a tertiary care center in Bangladesh. Sch Int J Obstet Gynec. 2024;7(5):223-228.
12. Hemida AS, Mohamed AA, El-Khouly NI, El-Kelani OA. Comparison of visual inspection with acetic acid and Pap smear for cervical cancer screening. Menoufia Med J. 2022;35(1):245-249.
13. Begum KN, Shahanaz S, Rashid F, Rehena Z, Chowdhury S, Sharmin S, et al. Visual inspection of cervix with acetic acid as a method of cervical cancer screening in tertiary hospital. IAHS Med J. 2021;4(1):22-26.
14. Sinha P, Srivastava P, Srivastava A. Comparison of visual inspection with acetic acid and the Pap smear for cervical cancer screening. Acta Cytol. 2018;62(1):34-38.
15. Kakollu M, Biswas PK, Yadala A. 794P Comparative study of effectiveness of Pap smear and visual inspection with acetic acid for screening of premalignant and malignant lesion of cervix in a tertiary care setup. Ann Oncol. 2021;32(Suppl 7):S759.
16. Jeffries A, Beck-Sagué CM, Marroquin-Garcia AB, Dean M, McCoy V, Cordova-Toma DA, et al. Cervical visual inspection with acetic acid (VIA) and oncogenic human papillomavirus screening in rural indigenous Guatemalan women: time to rethink VIA. Int J Environ Res Public Health. 2021;18(23):12406.
17. Mrudula DM, Venkatalakshmi A, Sirisha G, Kumar SS, Atla B. Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid for mass screening of lesions of cervix. Int J Res Med Sci. 2018;6(6):2042-2047.
18. Basanna SK, Charita U, Anuradha SN. Comparison of Pap smear with visual inspection with acetic acid in screening of carcinoma cervix. J Pharm Negat Results. 2022;13(1):4923-4933.
19. Zawua Z, Omietimi JE, Jeremiah I, Aigere S, Musa S, Osegi N, et al. 872P Comparison of colposcopy, Pap smear test and visual inspection with acetic acid (VIA) as screening tests for precancer of the cervix (CIN2+) in high-risk patients. Ann Oncol. 2020;31(Suppl 4):S642.
Published
Issue
Section
License
Copyright (c) 2025 Saba Khalid, Ayesha Azhar Khan, Muhammad Azeem Gulzar, Hafsa Hafeez, Zunaira Aslam
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a CC-BY 4.0 License.
